John Lafleur

420 total citations
20 papers, 278 citations indexed

About

John Lafleur is a scholar working on Pulmonary and Respiratory Medicine, Infectious Diseases and Molecular Biology. According to data from OpenAlex, John Lafleur has authored 20 papers receiving a total of 278 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 6 papers in Infectious Diseases and 6 papers in Molecular Biology. Recurrent topics in John Lafleur's work include Bacterial biofilms and quorum sensing (5 papers), Inhalation and Respiratory Drug Delivery (4 papers) and COVID-19 Clinical Research Studies (4 papers). John Lafleur is often cited by papers focused on Bacterial biofilms and quorum sensing (5 papers), Inhalation and Respiratory Drug Delivery (4 papers) and COVID-19 Clinical Research Studies (4 papers). John Lafleur collaborates with scholars based in United States, Australia and Saudi Arabia. John Lafleur's co-authors include John E. Vena, Janek Bzdrenga, Laurent Papazian, Hubert Lépidi, Sami Hraiech, Julien Hiblot, Jean‐Marc Rolain, Mikael Elias, Jeffrey M. Drazen and Mark W. Silby and has published in prestigious journals such as PLoS ONE, Journal of Hazardous Materials and Science Advances.

In The Last Decade

John Lafleur

18 papers receiving 272 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Lafleur United States 8 89 64 49 38 35 20 278
Leela Kakithakara Vajravelu India 9 104 1.2× 78 1.2× 39 0.8× 39 1.0× 47 1.3× 96 360
Jonathan J. Whittall Australia 11 114 1.3× 82 1.3× 19 0.4× 50 1.3× 88 2.5× 16 361
Ahmad M. Alharbi Saudi Arabia 10 126 1.4× 35 0.5× 13 0.3× 35 0.9× 22 0.6× 45 296
Wendy E. Kaman Netherlands 11 149 1.7× 30 0.5× 16 0.3× 52 1.4× 18 0.5× 15 391
Yanhong Qin China 13 124 1.4× 14 0.2× 25 0.5× 23 0.6× 45 1.3× 42 474
Jingjun Lin United States 12 100 1.1× 53 0.8× 21 0.4× 7 0.2× 34 1.0× 17 362
Alison A. Jack United Kingdom 8 157 1.8× 68 1.1× 37 0.8× 25 0.7× 36 1.0× 9 351
Rafael Coria‐Jiménez Mexico 12 178 2.0× 28 0.4× 28 0.6× 13 0.3× 102 2.9× 25 433
Tessa Horemans Belgium 7 172 1.9× 40 0.6× 16 0.3× 13 0.3× 26 0.7× 9 331
Siamak Heidarzadeh Iran 9 153 1.7× 53 0.8× 16 0.3× 21 0.6× 14 0.4× 38 360

Countries citing papers authored by John Lafleur

Since Specialization
Citations

This map shows the geographic impact of John Lafleur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Lafleur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Lafleur more than expected).

Fields of papers citing papers by John Lafleur

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Lafleur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Lafleur. The network helps show where John Lafleur may publish in the future.

Co-authorship network of co-authors of John Lafleur

This figure shows the co-authorship network connecting the top 25 collaborators of John Lafleur. A scholar is included among the top collaborators of John Lafleur based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Lafleur. John Lafleur is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mallory, Michael L., Jennifer E. Munt, Tara M. Narowski, et al.. (2024). COVID-19 point-of-care tests can identify low-antibody individuals: In-depth immunoanalysis of boosting benefits in a healthy cohort. Science Advances. 10(24). eadi1379–eadi1379.
2.
Jaatinen, Kevin, et al.. (2024). Blood RNA Biomarkers Identify Bacterial and Biofilm Coinfections in COVID-19 Intensive Care Patients. Journal of Intensive Care Medicine. 39(11). 1071–1082. 1 indexed citations
3.
Narowski, Tara M., Lily E. Adams, Nadja A. Vielot, et al.. (2022). SARS-CoV-2 mRNA vaccine induces robust specific and cross-reactive IgG and unequal neutralizing antibodies in naive and previously infected people. Cell Reports. 38(5). 110336–110336. 32 indexed citations
4.
Lafleur, John, et al.. (2022). RNA Sequencing in COVID-19 patients identifies neutrophil activation biomarkers as a promising diagnostic platform for infections. PLoS ONE. 17(1). e0261679–e0261679. 25 indexed citations
5.
Goeres, Darla M., et al.. (2022). Prevention of Biofilms in Catheter-Associated Urinary Tract Infections (CAUTIs): A Review. 61–97. 4 indexed citations
6.
Kim, Justin, Laura Bradley, Eugene S. Kim, et al.. (2021). 176: THE ROLE OF WHOLE BLOOD DEFA1 MRNA AS A BIOMARKER FOR COVID SEVERITY. Critical Care Medicine. 50(1). 72–72. 1 indexed citations
7.
Park, Daniel E., et al.. (2020). COVID-19 infection among emergency department healthcare providers in a large tertiary academic medical center following the peak of the pandemic. The American Journal of Emergency Medicine. 40. 27–31. 5 indexed citations
8.
Shen, Hongchen, David P. Durkin, Ashlee Aiello, et al.. (2020). Photocatalytic graphitic carbon nitride-chitosan composites for pathogenic biofilm control under visible light irradiation. Journal of Hazardous Materials. 408. 124890–124890. 31 indexed citations
9.
Lafleur, John, et al.. (2019). Aortic dissection in a 19 year old male without risk factors. The American Journal of Emergency Medicine. 38(2). 410.e1–410.e3.
10.
11.
Lafleur, John & Stuart A. Rice. (2014). Induction of resistance to S. aureus in an environmental marine biofilm grown in Sydney Harbor, NSW, Australia. World Journal of Microbiology and Biotechnology. 31(2). 353–358. 2 indexed citations
12.
Hraiech, Sami, Julien Hiblot, John Lafleur, et al.. (2014). Inhaled Lactonase Reduces Pseudomonas aeruginosa Quorum Sensing and Mortality in Rat Pneumonia. PLoS ONE. 9(10). e107125–e107125. 79 indexed citations
13.
Lafleur, John, et al.. (2013). Induction of resistance to Staphylococcus aureus in an environmental marine biofilm. Journal of Microbiological Methods. 93(1). 68–71. 5 indexed citations
14.
Lafleur, John, et al.. (2010). Acetazolamide and Exercise Hypoxia. International Journal of Sports Medicine. 31(6). 372–376. 2 indexed citations
15.
Lafleur, John, et al.. (2005). The effect of pesticide spraying on the rate and severity of ED asthma. The American Journal of Emergency Medicine. 23(4). 463–467. 18 indexed citations
16.
Lafleur, John, et al.. (2003). Cognitive Effects of Dexamethasone at High Altitude☆. Wilderness and Environmental Medicine. 14(1). 20–23. 5 indexed citations
17.
Lafleur, John & John E. Vena. (1991). Retrospective cohort mortality study of cancer among sewage plant workers. American Journal of Industrial Medicine. 19(1). 75–86. 21 indexed citations
18.
Ingenito, Edward P., Bohdan Pichurko, John Lafleur, et al.. (1990). Breathing pattern affects respiratory heat loss but not bronchoconstrictor response in asthma. Lung. 168(1). 23–34. 7 indexed citations
19.
Pichurko, Bohdan, R. H. Ingram, Richard I. Sperling, et al.. (1989). Localization of the Site of the Bronchoconstrictor Effects of Leukotriene C 4 Compared with That of Histamine in Asthmatic Subjects. American Review of Respiratory Disease. 140(2). 334–339. 17 indexed citations
20.
Ingenito, Edward P., et al.. (1988). Dissociation of Temperature-Gradient and Evaporative Heat Loss during Cold Gas Hyperventilation in Cold-induced Asthma. American Review of Respiratory Disease. 138(3). 540–546. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Leela Kakithakara Vajravelu Breakdown of academic impact, for papers by Jonathan J. Whittall Breakdown of academic impact, for papers by Ahmad M. Alharbi Breakdown of academic impact, for papers by Wendy E. Kaman Breakdown of academic impact, for papers by Yanhong Qin Breakdown of academic impact, for papers by Jingjun Lin Breakdown of academic impact, for papers by Alison A. Jack Breakdown of academic impact, for papers by Rafael Coria‐Jiménez Breakdown of academic impact, for papers by Tessa Horemans Breakdown of academic impact, for papers by Siamak Heidarzadeh
Rankless by CCL
2026